Guardant Health Ordered to Pay $245.2M for DNA Sequencing Patent Infringement
GH Guardant Health Inc
$163.18 -4.40%
View chart & analysis → 
- 1A U.S. court ordered Guardant Health (GH) to pay $245.2 million for infringing DNA sequencing patents held by TwinStrand and the University of Washington.
- 2The award covers damages, accumulated royalties, and interest across 11 products, with quarterly royalty payments of 6% due until the patents expire in March 2033.
- 3Guardant Health plans to appeal the ruling, and its shares fell 3.6% at the market open following the verdict.
This 3-line summary is compiled from the report below.
Investor's Business Daily +1 View original ↗
오늘의 AI 픽 5종목, 무료로 전부 공개합니다숨기는 것 없이 — 지난 픽의 성적표(S&P500 대비)까지 그대로 보여드립니다